NCT02655237 2019-03-22A Phase 3 Study to Evaluate the Efficacy and Safety of Relugolix (TAK-385) 40 mg Compared With Leuprorelin in the Treatment of Uterine FibroidsTakedaPhase 3 Completed281 enrolled 37 charts
NCT00683917 2014-08-21Pharmacokinetics, Safety and Efficacy Study of Proellex in Pre-menopausal Women With Symptomatic Uterine FibroidsRepros Therapeutics Inc.Phase 2 Terminated10 enrolled 1 chart